What is the history of Shire Pharmaceuticals?

Shire Pharmaceuticals has a rich history spanning over three decades. It was founded in 1986 as a small startup in the United Kingdom. Initially focusing on the development of calcium-based treatments for patients with rare diseases, Shire expanded its medical portfolio over the years. By the 1990s, the company diversified its product offerings, including treatments in neuroscience and gastrointestinal therapy. In 2001, Shire moved its headquarters to Ireland and subsequently expanded globally. Rapid growth continued through mergers and acquisitions, enhancing its expertise in specialty pharmaceuticals. Notably, Shire acquired numerous companies, broadening its therapeutic areas to include rare diseases, human genetic therapies, ADHD, and other complex conditions. In 2019, Shire merged with Takeda Pharmaceutical Company, becoming a wholly-owned subsidiary, while maintaining its commitment to innovative healthcare solutions worldwide.